Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma (FOCUS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02678572 |
|
Recruitment Status :
Recruiting
First Posted : February 10, 2016
Last Update Posted : January 29, 2020
|
Sponsor:
Delcath Systems Inc.
Collaborator:
IQVIA Biotech
Information provided by (Responsible Party):
Delcath Systems Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 1, 2020 |
| Estimated Study Completion Date : | June 15, 2020 |